\-\ Texto\\:\\ \ \(0\)\
\-\ patient\\ is\\ afebrile\\ with\\ an\\ unremarkable\\ physical\\ exam\\.\\ \\ no\\ recent\\ labs\ \(0\)\
\-\ young\\ children\\ with\\ stage\\ i\\ and\\ ii\\ reflux\\ can\\ usually\\ be\\ managed\\ medically\\ with\\ daily\\ prophylactic\\ antibiotics\\ and\\ followed\\ with\\ periodic\\ urine\\ cultures\\.\\ \\ approximately\\ 80\\%\\ of\\ these\\ children\\ will\\ have\\ resolution\\ of\\ reflux\\ within\\ 5\\ years\\.\\ \\ treatment\\ of\\ this\\ patient\\ should\\ include\\ daily\\ trimethoprim\\/sulfamethoxazole\\ or\\ nitrofurantoin\\ for\\ antimicrobial\\ prophylaxis\\ and\\ regular\\ urine\\ cultures\\ at\\ 1\\-3\\ month\\ intervals\\ until\\ 3\\ consecutive\\ cultures\\ are\\ negative\\.\\ \\ prophylaxis\\ should\\ be\\ continued\\ until\\ reflux\\ resolves\\ as\\ determined\\ by\\ annual\\ radionuclide\\ cystography\\.\ \(0\)\
\-\ voiding\\ cystourethrogram\\ \\(vcug\\)\\ shows\\ vesicoureteral\\ reflux\\ of\\ contrast\\ on\\ the\\ right\\ side\\ during\\ filling\\.\\ \\ the\\ contrast\\ extends\\ from\\ the\\ vesicoureteral\\ junction\\ to\\ the\\ central\\ collecting\\ system\\ showing\\ a\\ nondilated\\ ureter\\ and\\ renal\\ pelvis\\ with\\ normal\\ calyceal\\ fornices\\.\\ \\ no\\ vesicoureteral\\ reflux\\ is\\ seen\\ on\\ the\\ left\\ side\\.\ \(0\)\
\-\ right\\ grade\\ ii\\ vesicoureteral\\ reflux\ \(0\)\
\-\ right\\ grade\\ ii\\ vesicoureteral\\ reflux\ \(0\)\
\-\ 5\\ year\\-old\\ girl\\ with\\ history\\ of\\ treated\\ febrile\\,\\ right\\-sided\\ pyelonephritis\\ \\(culture\\ positive\\ for\\ \\>100\\,000\\ colony\\ forming\\ units\\ e\\.\\ coli\\)\\.\\ \\ family\\ history\\ of\\ vesicoureteral\\ reflux\ \(0\)\
\-\ demonstration\\ of\\ vesicoureteral\\ reflux\\ requires\\ either\\ a\\ voiding\\ cystourethrogram\\ \\(vcug\\)\\ or\\ a\\ radionuclide\\ cystogram\\ \\(rnc\\)\\,\\ and\\ long\\ term\\ complications\\ of\\ this\\ condition\\ include\\ recurrent\\ pyelonephritis\\,\\ renal\\ scarring\\,\\ end\\-stage\\ renal\\ failure\\,\\ and\\ late\\ secondary\\ hypertension\\.\\ \\ therefore\\ it\\ is\\ recommended\\ that\\ all\\ children\\ under\\ age\\ 7\\ with\\ a\\ first\\ uti\\ should\\ undergo\\ a\\ vcug\\ for\\ diagnosis\\ and\\ classification\\ of\\ reflux\\.1\\ \\ \\ \\ \\ international\\ classification\\ of\\ vesicoureteral\\ reflux\\:\\ \\ grade\\ i\\:\\ ureter\\ only\\ \\ grade\\ ii\\:\\ ureter\\,\\ pelvis\\,\\ and\\ calyces\\;\\ no\\ dilation\\,\\ normal\\ calyceal\\ fornices\\ \\ grade\\ iii\\:\\ mild\\ to\\ moderate\\ dilation\\ or\\ tortuosity\\ of\\ the\\ ureter\\/renal\\ pelvis\\;\\ slight\\ or\\ no\\ blunting\\ of\\ the\\ fornices\\ \\ grade\\ iv\\:\\ moderate\\ dilation\\ or\\ tortuosity\\ of\\ the\\ ureter\\/renal\\ pelvis\\;\\ complete\\ obliteration\\ of\\ sharp\\ angle\\ of\\ fornices\\,\\ but\\ maintenance\\ of\\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ \\ papillary\\ impressions\\ in\\ majority\\ of\\ calyces\\.\\ \\ grade\\ v\\:\\ gross\\ dilation\\ and\\ tortuosity\\ of\\ ureter\\/renal\\ pelvis\\;\\ papillary\\ impressions\\ are\\ no\\ longer\\ visible\\ in\\ the\\ majority\\ of\\ calyces\\.treatment\\ of\\ children\\ with\\ grades\\ 1\\-ii\\ reflux\\ is\\ usually\\ medical\\ therapy\\ with\\ prophylactic\\ antimicrobials\\ and\\ close\\ follow\\-up\\ \\(as\\ described\\ above\\ for\\ this\\ patient\\)\\.2\\ \\ surgical\\ options\\ \\(often\\ in\\ conjunction\\ with\\ medical\\ therapy\\)\\ exist\\ for\\ more\\ severe\\ reflux\\ \\(grades\\ iii\\-v\\)\\,\\ usually\\ consisting\\ of\\ open\\ surgical\\ reimplantation\\ of\\ the\\ vesicoureteral\\ junction\\,\\ although\\ some\\ investigations\\ of\\ less\\ invasive\\ techniques\\ are\\ promising\\.\\ \\ these\\ newer\\ techniques\\ include\\ laparoscopic\\ reimplantation\\ as\\ well\\ as\\ endoscopic\\ injection\\ of\\ materials\\ \\(e\\.g\\.\\ teflon\\)\\ behind\\ the\\ ureter\\ to\\ provide\\ a\\ valve\\ mechanism\\ during\\ bladder\\ filling\\ and\\ emptying\\.3\\,4\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ reflux\\:\\ 0\\.10598614693989035\ \(0\)\
\-\ vesicoureteral\\:\\ 0\\.10534227152034338\ \(0\)\
\-\ fornices\\:\\ 0\\.06027809290636834\ \(0\)\
\-\ ureter\\/renal\\:\\ 0\\.05916455318098321\ \(0\)\
\-\ grade\\:\\ 0\\.05097059854733063\ \(0\)\
\-\ tortuosity\\:\\ 0\\.04248732734347985\ \(0\)\
\-\ ureter\\:\\ 0\\.04126018617069828\ \(0\)\
\-\ vcug\\:\\ 0\\.03704484267088704\ \(0\)\
\-\ impressions\\:\\ 0\\.036341705787053924\ \(0\)\
\-\ dilation\\:\\ 0\\.0360449814871092\ \(0\)\
\-\ pelvis\\:\\ 0\\.03473256606925759\ \(0\)\
\-\ children\\:\\ 0\\.03303404424665091\ \(0\)\
\-\ ii\\:\\ 0\\.03298093699367718\ \(0\)\
\-\ grades\\:\\ 0\\.03142621456258811\ \(0\)\
\-\ cystourethrogram\\:\\ 0\\.03013904645318417\ \(0\)\
\-\ cultures\\:\\ 0\\.029507904806509395\ \(0\)\
\-\ reimplantation\\:\\ 0\\.029140641301890167\ \(0\)\
\-\ radionuclide\\:\\ 0\\.027326479744359228\ \(0\)\
\-\ calyceal\\:\\ 0\\.027326479744359228\ \(0\)\
\-\ voiding\\:\\ 0\\.0267664656819252\ \(0\)\
\-\ calyces\\:\\ 0\\.025413978559451225\ \(0\)\
\-\ prophylaxis\\:\\ 0\\.023936387119314412\ \(0\)\
\-\ prophylactic\\:\\ 0\\.023535437863432145\ \(0\)\
\-\ techniques\\:\\ 0\\.022827500479920316\ \(0\)\
\-\ pyelonephritis\\:\\ 0\\.022312648892516346\ \(0\)\
\-\ classification\\:\\ 0\\.02185097445745938\ \(0\)\
\-\ daily\\:\\ 0\\.019781070556125543\ \(0\)\
\-\ trimethoprim\\/sulfamethoxazole\\:\\ 0\\.019721517726994403\ \(0\)\
\-\ colony\\:\\ 0\\.019721517726994403\ \(0\)\
\-\ rnc\\:\\ 0\\.019721517726994403\ \(0\)\
\-\ reflux\\.1\\:\\ 0\\.019721517726994403\ \(0\)\
\-\ calyces\\.treatment\\:\\ 0\\.019721517726994403\ \(0\)\
\-\ 1\\-ii\\:\\ 0\\.019721517726994403\ \(0\)\
\-\ antimicrobials\\:\\ 0\\.019721517726994403\ \(0\)\
\-\ teflon\\:\\ 0\\.019721517726994403\ \(0\)\
\-\ emptying\\.3\\,4\\:\\ 0\\.019721517726994403\ \(0\)\
\-\ papillary\\:\\ 0\\.019410208543571773\ \(0\)\
\-\ majority\\:\\ 0\\.0187937266538042\ \(0\)\
\-\ urine\\:\\ 0\\.018452664616274518\ \(0\)\
\-\ should\\:\\ 0\\.01828327880462282\ \(0\)\
\-\ iii\\-v\\:\\ 0\\.018170852893526962\ \(0\)\
\-\ \\;\\:\\ 0\\.0181245743933118\ \(0\)\
\-\ usually\\:\\ 0\\.017415625864877576\ \(0\)\
\-\ nitrofurantoin\\:\\ 0\\.017263772114761496\ \(0\)\
\-\ promising\\:\\ 0\\.017263772114761496\ \(0\)\
\-\ renal\\:\\ 0\\.01723137952656422\ \(0\)\
\-\ until\\:\\ 0\\.016791603538879336\ \(0\)\
\-\ nondilated\\:\\ 0\\.016620188060059524\ \(0\)\
\-\ materials\\:\\ 0\\.016620188060059524\ \(0\)\
\-\ consecutive\\:\\ 0\\.01612098548441252\ \(0\)\
\-\ include\\:\\ 0\\.016088278443156287\ \(0\)\
\-\ junction\\:\\ 0\\.016013764926785454\ \(0\)\
\-\ i\\:\\ 0\\.01580454002339378\ \(0\)\
\-\ cystography\\:\\ 0\\.015713107281294054\ \(0\)\
\-\ filling\\:\\ 0\\.015392572779786725\ \(0\)\
\-\ cystogram\\:\\ 0\\.015368251174297952\ \(0\)\
\-\ \\:\\:\\ 0\\.015171474040143155\ \(0\)\
\-\ antimicrobial\\:\\ 0\\.015069523226592085\ \(0\)\
\-\ investigations\\:\\ 0\\.015069523226592085\ \(0\)\
\-\ moderate\\:\\ 0\\.015034439859547189\ \(0\)\
\-\ newer\\:\\ 0\\.014806026502528586\ \(0\)\
\-\ 100\\,000\\:\\ 0\\.014570320650945084\ \(0\)\
\-\ \\.2\\:\\ 0\\.014162442447826617\ \(0\)\
\-\ 1\\-3\\:\\ 0\\.013983375987706848\ \(0\)\
\-\ intervals\\:\\ 0\\.013983375987706848\ \(0\)\
\-\ resolves\\:\\ 0\\.013983375987706848\ \(0\)\
\-\ maintenance\\:\\ 0\\.013817586340830513\ \(0\)\
\-\ end\\-stage\\:\\ 0\\.013663239872179614\ \(0\)\
\-\ international\\:\\ 0\\.0133832328409626\ \(0\)\
\-\ side\\:\\ 0\\.013245845645476827\ \(0\)\
\-\ forming\\:\\ 0\\.013134405916778653\ \(0\)\
\-\ coli\\:\\ 0\\.013134405916778653\ \(0\)\
\-\ exist\\:\\ 0\\.013134405916778653\ \(0\)\
\-\ conjunction\\:\\ 0\\.013019655817477644\ \(0\)\
\-\ \\(\\:\\ 0\\.012928174071478489\ \(0\)\
\-\ medically\\:\\ 0\\.012910505562065045\ \(0\)\
\-\ blunting\\:\\ 0\\.012806433938720765\ \(0\)\
\-\ obliteration\\:\\ 0\\.012806433938720765\ \(0\)\
\-\ \\)\\:\\ 0\\.012770249523280628\ \(0\)\
\-\ demonstration\\:\\ 0\\.01234828089029568\ \(0\)\
\-\ periodic\\:\\ 0\\.01218841743619692\ \(0\)\
\-\ uti\\:\\ 0\\.012112575038712175\ \(0\)\
\-\ consisting\\:\\ 0\\.012039219730383337\ \(0\)\
\-\ laparoscopic\\:\\ 0\\.011899353159955297\ \(0\)\
\-\ units\\:\\ 0\\.011767718931716072\ \(0\)\
\-\ medical\\:\\ 0\\.01176424966472485\ \(0\)\
\-\ during\\:\\ 0\\.011700265100330237\ \(0\)\
\-\ e\\.\\:\\ 0\\.011583741083311214\ \(0\)\
\-\ as\\:\\ 0\\.011566689090775193\ \(0\)\
\-\ endoscopic\\:\\ 0\\.011255769105253326\ \(0\)\
\-\ or\\:\\ 0\\.01120271531279315\ \(0\)\
\-\ 5\\:\\ 0\\.011186400100421313\ \(0\)\
\-\ scarring\\:\\ 0\\.011156324446258173\ \(0\)\
\-\ febrile\\:\\ 0\\.011014984621601501\ \(0\)\
\-\ longer\\:\\ 0\\.010797616056828241\ \(0\)\
\-\ provide\\:\\ 0\\.010716256673895634\ \(0\)\
\-\ v\\:\\ 0\\.010488554896915898\ \(0\)\
\-\ sharp\\:\\ 0\\.010348688326487858\ \(0\)\
\-\ managed\\:\\ 0\\.010281903174027721\ \(0\)\
\-\ therapy\\:\\ 0\\.010222106470875226\ \(0\)\
\-\ culture\\:\\ 0\\.010185321134060812\ \(0\)\
\-\ requires\\:\\ 0\\.01015403200212627\ \(0\)\
\-\ e\\.g\\:\\ 0\\.010123174458206057\ \(0\)\
\-\ behind\\:\\ 0\\.010092736757857558\ \(0\)\
\-\ determined\\:\\ 0\\.009974965542006503\ \(0\)\
\-\ these\\:\\ 0\\.009950088107193914\ \(0\)\
\-\ late\\:\\ 0\\.009946466602907107\ \(0\)\
\-\ mechanism\\:\\ 0\\.009835968268836466\ \(0\)\
\-\ collecting\\:\\ 0\\.009756534961326599\ \(0\)\
\-\ undergo\\:\\ 0\\.009705104271785886\ \(0\)\
\-\ no\\:\\ 0\\.00962465492957273\ \(0\)\
\-\ invasive\\:\\ 0\\.009605659612790734\ \(0\)\
\-\ annual\\:\\ 0\\.00958147411815043\ \(0\)\
\-\ valve\\:\\ 0\\.009557547296860166\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.009331381487304531\ \(0\)\
\-\ close\\:\\ 0\\.009331381487304531\ \(0\)\
\-\ options\\:\\ 0\\.009288768075736982\ \(0\)\
\-\ gross\\:\\ 0\\.009106457037143731\ \(0\)\
\-\ visible\\:\\ 0\\.009048845189039895\ \(0\)\
\-\ therefore\\:\\ 0\\.00902996628826615\ \(0\)\
\-\ 80\\:\\ 0\\.008992679817382006\ \(0\)\
\-\ slight\\:\\ 0\\.008992679817382006\ \(0\)\
\-\ iii\\:\\ 0\\.008974267067635888\ \(0\)\
\-\ angle\\:\\ 0\\.008974267067635888\ \(0\)\
\-\ injection\\:\\ 0\\.008919920999248763\ \(0\)\
\-\ afebrile\\:\\ 0\\.008832178911657529\ \(0\)\
\-\ regular\\:\\ 0\\.008815036019609276\ \(0\)\
\-\ showing\\:\\ 0\\.008798023493020418\ \(0\)\
\-\ term\\:\\ 0\\.0087477486477138\ \(0\)\
\-\ contrast\\:\\ 0\\.008558280477887719\ \(0\)\
\-\ open\\:\\ 0\\.008497178047318957\ \(0\)\
\-\ under\\:\\ 0\\.008353722727029162\ \(0\)\
\-\ young\\:\\ 0\\.008326103407516187\ \(0\)\
\-\ either\\:\\ 0\\.008326103407516187\ \(0\)\
\-\ extends\\:\\ 0\\.008285303435369026\ \(0\)\
\-\ resolution\\:\\ 0\\.008245234248419294\ \(0\)\
\-\ continued\\:\\ 0\\.00823203576491328\ \(0\)\
\-\ for\\:\\ 0\\.00815557213246885\ \(0\)\
\-\ stage\\:\\ 0\\.008154439438318449\ \(0\)\
\-\ described\\:\\ 0\\.008141764410274427\ \(0\)\
\-\ recurrent\\:\\ 0\\.00806718628887042\ \(0\)\
\-\ surgical\\:\\ 0\\.008036786444078093\ \(0\)\
\-\ condition\\:\\ 0\\.00799501433759923\ \(0\)\
\-\ recommended\\:\\ 0\\.007925098132892062\ \(0\)\
\-\ family\\:\\ 0\\.007835150883500471\ \(0\)\
\-\ are\\:\\ 0\\.007817945453218803\ \(0\)\
\-\ bladder\\:\\ 0\\.007759308486015725\ \(0\)\
\-\ complications\\:\\ 0\\.007575330637610866\ \(0\)\
\-\ hypertension\\:\\ 0\\.007536422935794604\ \(0\)\
\-\ system\\:\\ 0\\.007526800828637131\ \(0\)\
\-\ failure\\:\\ 0\\.007488720990674199\ \(0\)\
\-\ 7\\:\\ 0\\.007324954986147812\ \(0\)\
\-\ antibiotics\\:\\ 0\\.007180573507092843\ \(0\)\
\-\ year\\-old\\:\\ 0\\.007021844791271178\ \(0\)\
\-\ above\\:\\ 0\\.007006574175901155\ \(0\)\
\-\ iv\\:\\ 0\\.006976342141971127\ \(0\)\
\-\ complete\\:\\ 0\\.006727910366859182\ \(0\)\
\-\ girl\\:\\ 0\\.0067212023064648725\ \(0\)\
\-\ \\,\\:\\ 0\\.006661768950089846\ \(0\)\
\-\ labs\\:\\ 0\\.006648711424910823\ \(0\)\
\-\ long\\:\\ 0\\.006591099576806988\ \(0\)\
\-\ less\\:\\ 0\\.00647413871213128\ \(0\)\
\-\ although\\:\\ 0\\.0064562176299252875\ \(0\)\
\-\ this\\:\\ 0\\.006450585324255926\ \(0\)\
\-\ recent\\:\\ 0\\.006426664538791493\ \(0\)\
\-\ first\\:\\ 0\\.006414951755673047\ \(0\)\
\-\ followed\\:\\ 0\\.006409118280489422\ \(0\)\
\-\ \\>\\:\\ 0\\.006351605178229451\ \(0\)\
\-\ unremarkable\\:\\ 0\\.006329007648058301\ \(0\)\
\-\ central\\:\\ 0\\.006290003035480893\ \(0\)\
\-\ of\\:\\ 0\\.0062552376267376334\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.006219322128505016\ \(0\)\
\-\ positive\\:\\ 0\\.006203323468197129\ \(0\)\
\-\ often\\:\\ 0\\.006099493397135687\ \(0\)\
\-\ right\\:\\ 0\\.006051219524230984\ \(0\)\
\-\ normal\\:\\ 0\\.005993791743172712\ \(0\)\
\-\ will\\:\\ 0\\.00598094187556855\ \(0\)\
\-\ approximately\\:\\ 0\\.005914581267462154\ \(0\)\
\-\ be\\:\\ 0\\.005896003236438162\ \(0\)\
\-\ severe\\:\\ 0\\.005882124832362425\ \(0\)\
\-\ age\\:\\ 0\\.0058185913323138844\ \(0\)\
\-\ some\\:\\ 0\\.005805208621625859\ \(0\)\
\-\ patient\\:\\ 0\\.005748939133667033\ \(0\)\
\-\ only\\:\\ 0\\.005748124515626254\ \(0\)\
\-\ month\\:\\ 0\\.005735155572260871\ \(0\)\
\-\ treated\\:\\ 0\\.005722261378263667\ \(0\)\
\-\ negative\\:\\ 0\\.005709441076901285\ \(0\)\
\-\ years\\:\\ 0\\.0056135193221889985\ \(0\)\
\-\ all\\:\\ 0\\.005406987672105796\ \(0\)\
\-\ secondary\\:\\ 0\\.005344586054829547\ \(0\)\
\-\ a\\:\\ 0\\.005323487272732903\ \(0\)\
\-\ history\\:\\ 0\\.005280601958420955\ \(0\)\
\-\ shows\\:\\ 0\\.0052558695743375365\ \(0\)\
\-\ mild\\:\\ 0\\.005034124058011492\ \(0\)\
\-\ is\\:\\ 0\\.005031684817760408\ \(0\)\
\-\ more\\:\\ 0\\.004781155054389634\ \(0\)\
\-\ physical\\:\\ 0\\.004690168388324918\ \(0\)\
\-\ 3\\:\\ 0\\.0044764553170168675\ \(0\)\
\-\ \\%\\:\\ 0\\.004459331170796437\ \(0\)\
\-\ and\\:\\ 0\\.004429751818913653\ \(0\)\
\-\ diagnosis\\:\\ 0\\.004389752417853288\ \(0\)\
\-\ can\\:\\ 0\\.004336067902615368\ \(0\)\
\-\ well\\:\\ 0\\.004324565890310181\ \(0\)\
\-\ it\\:\\ 0\\.004297199965398247\ \(0\)\
\-\ exam\\:\\ 0\\.004199628501005678\ \(0\)\
\-\ have\\:\\ 0\\.004139682501935328\ \(0\)\
\-\ but\\:\\ 0\\.004077188592916192\ \(0\)\
\-\ treatment\\:\\ 0\\.0038693891713666374\ \(0\)\
\-\ seen\\:\\ 0\\.0037776904140216783\ \(0\)\
\-\ within\\:\\ 0\\.0036468264169710997\ \(0\)\
\-\ the\\:\\ 0\\.0034021076772704334\ \(0\)\
\-\ that\\:\\ 0\\.003301970309974996\ \(0\)\
\-\ on\\:\\ 0\\.0032388859613665683\ \(0\)\
\-\ by\\:\\ 0\\.003183156383098154\ \(0\)\
\-\ to\\:\\ 0\\.00286622891572474\ \(0\)\
\-\ from\\:\\ 0\\.0028331895148863808\ \(0\)\
\-\ in\\:\\ 0\\.0028281693298003686\ \(0\)\
\-\ an\\:\\ 0\\.002643545557683959\ \(0\)\
\-\ with\\:\\ 0\\.0026175430892592783\ \(0\)\
\-\ at\\:\\ 0\\.002590074167408575\ \(0\)\
\-\ left\\:\\ 0\\.0021389379625792277\ \(0\)\
\-\ \\.\\:\\ 0\\.0010324249871711444\ \(0\)\
